US 9006197
Compositions and methods for inhibiting expression of Eg5 and VEGF genes
granted A61KA61K31/713A61P
Quick answer
US patent 9006197 (Compositions and methods for inhibiting expression of Eg5 and VEGF genes) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/713, A61P, A61P35/00, A61P43/00